TRPM7 and cancer: TRPM7 overexpression, intracellular calcium rise, and nuclear stiffening emerge as promising strategies to inhibit the downstream migration of lamin A/Clow cancer cells and, thus, their escape from high-pressure environments, such as the primary tumor.